Cargando…
Effect of Glyceryl Trinitrate on Hemodynamics in Acute Stroke: Data From the ENOS Trial
BACKGROUND AND PURPOSE—: Increased blood pressure (BP), heart rate, and their derivatives (variability, pulse pressure, rate-pressure product) are associated with poor clinical outcome in acute stroke. We assessed the effects of glyceryl trinitrate (GTN) on hemodynamic parameters and these on outcom...
Autores principales: | , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6358219/ https://www.ncbi.nlm.nih.gov/pubmed/30626285 http://dx.doi.org/10.1161/STROKEAHA.118.023190 |
_version_ | 1783391971058909184 |
---|---|
author | Appleton, Jason P. Woodhouse, Lisa J. Bereczki, Daniel Berge, Eivind Christensen, Hanne K. Collins, Rónán Gommans, John Ntaios, George Ozturk, Serefnur Szatmari, Szabolcs Wardlaw, Joanna M. Sprigg, Nikola Rothwell, Peter M. Bath, Philip M. |
author_facet | Appleton, Jason P. Woodhouse, Lisa J. Bereczki, Daniel Berge, Eivind Christensen, Hanne K. Collins, Rónán Gommans, John Ntaios, George Ozturk, Serefnur Szatmari, Szabolcs Wardlaw, Joanna M. Sprigg, Nikola Rothwell, Peter M. Bath, Philip M. |
author_sort | Appleton, Jason P. |
collection | PubMed |
description | BACKGROUND AND PURPOSE—: Increased blood pressure (BP), heart rate, and their derivatives (variability, pulse pressure, rate-pressure product) are associated with poor clinical outcome in acute stroke. We assessed the effects of glyceryl trinitrate (GTN) on hemodynamic parameters and these on outcome in participants in the ENOS trial (Efficacy of Nitric Oxide in Stroke). METHODS—: Four thousand and eleven patients with acute stroke and raised BP were randomized within 48 hours of onset to transdermal GTN or no GTN for 7 days. Peripheral hemodynamics were measured at baseline (3 measures) and daily (2 measures) during treatment. Between-visit BP variability over days 1 to 7 (as SD) was assessed in quintiles. Functional outcome was assessed as modified Rankin Scale and cognition as telephone mini-mental state examination at day 90. Analyses were adjusted for baseline prognostic variables. Data are mean difference or odds ratios with 95% CI. RESULTS—: Increased baseline BP (diastolic, variability), heart rate, and rate-pressure product were each associated with unfavorable functional outcome at day 90. Increased between-visit systolic BP variability was associated with an unfavourable shift in modified Rankin Scale (highest quintile adjusted odds ratio, 1.65; 95% CI, 1.37–1.99), worse cognitive scores (telephone mini-mental state examination: highest quintile adjusted mean difference, −2.03; 95% CI, −2.84 to −1.22), and increased odds of death at day 90 (highest quintile adjusted odds ratio, 1.57; 95% CI, 1.12–2.19). GTN lowered BP and rate-pressure product and increased heart rate at day 1 and reduced between-visit systolic BP variability. CONCLUSIONS—: Increased between-visit BP variability was associated with poor functional and cognitive outcomes and increased death 90 days after acute stroke. In addition to lowering BP and rate-pressure product, GTN reduced between-visit systolic BP variability. Agents that lower BP variability in acute stroke require further study. |
format | Online Article Text |
id | pubmed-6358219 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | Lippincott Williams & Wilkins |
record_format | MEDLINE/PubMed |
spelling | pubmed-63582192019-02-20 Effect of Glyceryl Trinitrate on Hemodynamics in Acute Stroke: Data From the ENOS Trial Appleton, Jason P. Woodhouse, Lisa J. Bereczki, Daniel Berge, Eivind Christensen, Hanne K. Collins, Rónán Gommans, John Ntaios, George Ozturk, Serefnur Szatmari, Szabolcs Wardlaw, Joanna M. Sprigg, Nikola Rothwell, Peter M. Bath, Philip M. Stroke Original Contributions BACKGROUND AND PURPOSE—: Increased blood pressure (BP), heart rate, and their derivatives (variability, pulse pressure, rate-pressure product) are associated with poor clinical outcome in acute stroke. We assessed the effects of glyceryl trinitrate (GTN) on hemodynamic parameters and these on outcome in participants in the ENOS trial (Efficacy of Nitric Oxide in Stroke). METHODS—: Four thousand and eleven patients with acute stroke and raised BP were randomized within 48 hours of onset to transdermal GTN or no GTN for 7 days. Peripheral hemodynamics were measured at baseline (3 measures) and daily (2 measures) during treatment. Between-visit BP variability over days 1 to 7 (as SD) was assessed in quintiles. Functional outcome was assessed as modified Rankin Scale and cognition as telephone mini-mental state examination at day 90. Analyses were adjusted for baseline prognostic variables. Data are mean difference or odds ratios with 95% CI. RESULTS—: Increased baseline BP (diastolic, variability), heart rate, and rate-pressure product were each associated with unfavorable functional outcome at day 90. Increased between-visit systolic BP variability was associated with an unfavourable shift in modified Rankin Scale (highest quintile adjusted odds ratio, 1.65; 95% CI, 1.37–1.99), worse cognitive scores (telephone mini-mental state examination: highest quintile adjusted mean difference, −2.03; 95% CI, −2.84 to −1.22), and increased odds of death at day 90 (highest quintile adjusted odds ratio, 1.57; 95% CI, 1.12–2.19). GTN lowered BP and rate-pressure product and increased heart rate at day 1 and reduced between-visit systolic BP variability. CONCLUSIONS—: Increased between-visit BP variability was associated with poor functional and cognitive outcomes and increased death 90 days after acute stroke. In addition to lowering BP and rate-pressure product, GTN reduced between-visit systolic BP variability. Agents that lower BP variability in acute stroke require further study. Lippincott Williams & Wilkins 2019-02 2019-01-10 /pmc/articles/PMC6358219/ /pubmed/30626285 http://dx.doi.org/10.1161/STROKEAHA.118.023190 Text en © 2019 The Authors. Stroke is published on behalf of the American Heart Association, Inc., by Wolters Kluwer Health, Inc. This is an open access article under the terms of the Creative Commons Attribution (https://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution, and reproduction in any medium, provided that the original work is properly cited. |
spellingShingle | Original Contributions Appleton, Jason P. Woodhouse, Lisa J. Bereczki, Daniel Berge, Eivind Christensen, Hanne K. Collins, Rónán Gommans, John Ntaios, George Ozturk, Serefnur Szatmari, Szabolcs Wardlaw, Joanna M. Sprigg, Nikola Rothwell, Peter M. Bath, Philip M. Effect of Glyceryl Trinitrate on Hemodynamics in Acute Stroke: Data From the ENOS Trial |
title | Effect of Glyceryl Trinitrate on Hemodynamics in Acute Stroke: Data From the ENOS Trial |
title_full | Effect of Glyceryl Trinitrate on Hemodynamics in Acute Stroke: Data From the ENOS Trial |
title_fullStr | Effect of Glyceryl Trinitrate on Hemodynamics in Acute Stroke: Data From the ENOS Trial |
title_full_unstemmed | Effect of Glyceryl Trinitrate on Hemodynamics in Acute Stroke: Data From the ENOS Trial |
title_short | Effect of Glyceryl Trinitrate on Hemodynamics in Acute Stroke: Data From the ENOS Trial |
title_sort | effect of glyceryl trinitrate on hemodynamics in acute stroke: data from the enos trial |
topic | Original Contributions |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6358219/ https://www.ncbi.nlm.nih.gov/pubmed/30626285 http://dx.doi.org/10.1161/STROKEAHA.118.023190 |
work_keys_str_mv | AT appletonjasonp effectofglyceryltrinitrateonhemodynamicsinacutestrokedatafromtheenostrial AT woodhouselisaj effectofglyceryltrinitrateonhemodynamicsinacutestrokedatafromtheenostrial AT bereczkidaniel effectofglyceryltrinitrateonhemodynamicsinacutestrokedatafromtheenostrial AT bergeeivind effectofglyceryltrinitrateonhemodynamicsinacutestrokedatafromtheenostrial AT christensenhannek effectofglyceryltrinitrateonhemodynamicsinacutestrokedatafromtheenostrial AT collinsronan effectofglyceryltrinitrateonhemodynamicsinacutestrokedatafromtheenostrial AT gommansjohn effectofglyceryltrinitrateonhemodynamicsinacutestrokedatafromtheenostrial AT ntaiosgeorge effectofglyceryltrinitrateonhemodynamicsinacutestrokedatafromtheenostrial AT ozturkserefnur effectofglyceryltrinitrateonhemodynamicsinacutestrokedatafromtheenostrial AT szatmariszabolcs effectofglyceryltrinitrateonhemodynamicsinacutestrokedatafromtheenostrial AT wardlawjoannam effectofglyceryltrinitrateonhemodynamicsinacutestrokedatafromtheenostrial AT spriggnikola effectofglyceryltrinitrateonhemodynamicsinacutestrokedatafromtheenostrial AT rothwellpeterm effectofglyceryltrinitrateonhemodynamicsinacutestrokedatafromtheenostrial AT bathphilipm effectofglyceryltrinitrateonhemodynamicsinacutestrokedatafromtheenostrial |